tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
ANI Pharmaceuticals Reports Record Q3 2025 Results
PremiumCompany AnnouncementsANI Pharmaceuticals Reports Record Q3 2025 Results
1M ago
ANI Pharmaceuticals: Strong Commercial Execution and Promising Growth Prospects Reinforce Buy Rating
Premium
Ratings
ANI Pharmaceuticals: Strong Commercial Execution and Promising Growth Prospects Reinforce Buy Rating
1M ago
ANI Pharmaceuticals raises FY25 adj. EPS view to $7.37-$7.64 from $6.98-$7.35
Premium
The Fly
ANI Pharmaceuticals raises FY25 adj. EPS view to $7.37-$7.64 from $6.98-$7.35
1M ago
Strong Growth Potential for ANI Pharmaceuticals Driven by Cortrophin Gel and Strategic Expansion
PremiumRatingsStrong Growth Potential for ANI Pharmaceuticals Driven by Cortrophin Gel and Strategic Expansion
3M ago
ANI Pharmaceuticals price target raised to $115 from $95 at JPMorgan
Premium
The Fly
ANI Pharmaceuticals price target raised to $115 from $95 at JPMorgan
3M ago
ANI Pharmaceuticals price target raised to $121 from $93 at H.C. Wainwright
Premium
The Fly
ANI Pharmaceuticals price target raised to $121 from $93 at H.C. Wainwright
3M ago
ANI Pharmaceuticals Reports Record Growth in Q2 2025
PremiumCompany AnnouncementsANI Pharmaceuticals Reports Record Growth in Q2 2025
4M ago
ANI Pharmaceuticals price target raised to $93 from $84 at H.C. Wainwright
Premium
The Fly
ANI Pharmaceuticals price target raised to $93 from $84 at H.C. Wainwright
4M ago
ANI Pharmaceuticals price target raised to $94 from $80 at Piper Sandler
Premium
The Fly
ANI Pharmaceuticals price target raised to $94 from $80 at Piper Sandler
4M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100